Kestra Medical Technologies, Ltd. (KMTS)
| Market Cap | 1.64B +112.1% |
| Revenue (ttm) | 95.13M +59.0% |
| Net Income | -131.61M |
| EPS | -2.43 |
| Shares Out | 58.60M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 85,886 |
| Open | 27.37 |
| Previous Close | 27.74 |
| Day's Range | 26.52 - 28.05 |
| 52-Week Range | 15.06 - 30.00 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 30.00 (+7.41%) |
| Earnings Date | Sep 10, 2026 |
About KMTS
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease through connected monitoring, therapeutic intervention, and data-driven clinical insights. The company also develops and commercializes Cardiac Recovery System platform, an integrated cardiac recovery ecosystem designed to support patients at elevated risk of sudden cardiac arrest (SCA) during vulnerable periods of recovery. Its platform provides ASSURE Wearable Cardioverte... [Read more]
Financial Performance
In fiscal year 2026, KMTS's revenue was $95.13 million, an increase of 59.03% compared to the previous year's $59.82 million. Losses were -$131.61 million, 4.34% more than in 2025.
Financial StatementsAnalyst Summary
According to 8 analysts, the average rating for KMTS stock is "Buy." The 12-month stock price target is $30.0, which is an increase of 7.41% from the latest price.
News
Kestra Medical initiated with an Overweight at JPMorgan
JPMorgan analyst Robbie Marcus initiated coverage of Kestra Medical (KMTS) with an Overweight rating and $30 price target Kestra is a commercial-stage wearable medical device and digital health compan...
Kestra Medical Technologies Proxy statement: Proxy filing
Kestra Medical Technologies filed a proxy statement on July 28, 2026, providing details for shareholder voting and corporate governance matters.
Kestra Medical Technologies Proxy statement: Proxy filing
Kestra Medical Technologies filed a proxy statement on July 28, 2026, providing details for shareholder voting and corporate governance matters.
Kestra Medical initiated with a Perform at Oppenheimer
Oppenheimer initiated coverage of Kestra Medical (KMTS) with a Perform rating and no price target The firm is bullish on the company’s fundamentals but prefers a better entry point into…
Kestra Medical price target raised to $32 from $30 at BTIG
BTIG raised the firm’s price target on Kestra Medical (KMTS) to $32 from $30 and keeps a Buy rating on the shares. The company’s Q4 revenue beat was driven by…
Kestra Medical Technologies Earnings Call Transcript: Q4 2026
Revenue grew 66% in Q4 and 59% for FY 2026, with gross margin expanding over 10 points year-over-year. FY 2027 guidance targets 44% revenue growth and further margin improvement, driven by sales force expansion, clinical evidence, and operational leverage.
Kestra Medical Technologies Earnings release: Q4 2026
Kestra Medical Technologies released its Q4 2026 earnings on July 14, 2026, summarizing the period's financial results.
Kestra Medical Technologies Annual report: Q4 2026
Kestra Medical Technologies has published its Q4 2026 annual report on July 14, 2026.
Kestra Medical Technologies Secures Up to $200 Million of Non-Dilutive Financing
KIRKLAND, Wash., July 14, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced that it has enter...
Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2026 Financial Results
KIRKLAND, Wash., July 14, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial results ...
Kestra Medical Technologies Slides: Company presentation
Kestra Medical Technologies has posted slides in relation to its latest quarterly earnings report, which was published on July 14, 2026.
Kestra Medical Technologies to Report Fourth Quarter Fiscal 2026 Financial Results on July 14
KIRKLAND, Wash., June 30, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, is scheduled to report fourth qua...
Kestra Medical Technologies Transcript: Bank of America Global Healthcare Conference 2026
Strong FY 2026 momentum was driven by expanded payer coverage and a larger, more productive sales force, resulting in rapid market share gains and robust revenue growth. Clinical data and innovation are expected to drive further market expansion, margin improvement, and new product launches, with partnerships like Biobeat enhancing future revenue opportunities.
Kestra Medical Technologies to Present at the BofA Securities 2026 Healthcare Conference
KIRKLAND, Wash., April 29, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd.
Kestra Showcases Accelerated Innovation at HRS 2026
KIRKLAND, Wash., April 22, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd.
Kestra Medical price target lowered to $30 from $32 at BTIG
BTIG lowered the firm’s price target on Kestra Medical (KMTS) to $30 from $32 and keeps a Buy rating on the shares as part of a broader research name on…
Kestra Medical Technologies Named a 2026 USA TODAY Top Workplaces Award Winner
KIRKLAND, Wash., April 09, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd.
Kestra Medical files automatic common shares offering
16:35 EDT Kestra Medical (KMTS) files automatic common shares offering
Kestra Medical Technologies Named Finalist for 2026 GeekWire “Deal of the Year”
KIRKLAND, Wash., March 25, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced it has been name...
Kestra Medical Technologies Earnings Call Transcript: Q3 2026
Q3 revenue grew 63% year-over-year to $24.6M, with gross margin up to 52.6% and strong prescription growth. Fiscal 2026 revenue guidance was raised to $93M, and recent payer wins in Florida and the VA are expected to drive further growth and margin expansion.
Kestra Medical Technologies Quarterly report: Q3 2026
Kestra Medical Technologies has published its Q3 2026 quarterly earnings report on March 17, 2026.
Kestra Medical Technologies Earnings release: Q3 2026
Kestra Medical Technologies released its Q3 2026 earnings on March 17, 2026, summarizing the period's financial results.
Kestra Medical Technologies Reports Third Quarter Fiscal 2026 Financial Results
KIRKLAND, Wash., March 17, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial results...
Kestra Medical Technologies Slides: Company presentation
Kestra Medical Technologies has posted slides in relation to its latest quarterly earnings report, which was published on March 17, 2026.
Kestra Medical Technologies to Report Third Quarter Fiscal 2026 Financial Results on March 17
KIRKLAND, Wash., March 03, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced that it will rep...